4basebio PLC (AIM:4BB)
London
· Delayed Price · Currency is GBP · Price in GBX 1,120.00
0.00 (0.00%)
Feb 21, 2025, 8:01 AM GMT+1
4basebio Revenue
4basebio had revenue of 328.00K GBP in the half year ending June 30, 2024, with 115.79% growth. This brings the company's revenue in the last twelve months to 596.00K, up 68.36% year-over-year. In the year 2023, 4basebio had annual revenue of 506.00K with 88.81% growth.
Revenue (ttm)
596.00K
Revenue Growth
+68.36%
P/S Ratio
235.17
Revenue / Employee
5.90K
Employees
84
Market Cap
143.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 506.00K | 238.00K | 88.81% |
| Dec 31, 2022 | 268.00K | -70.00K | -20.71% |
| Dec 31, 2021 | 338.00K | -124.00K | -26.84% |
| Dec 31, 2020 | 462.00K | -346.00K | -42.82% |
| Dec 31, 2019 | 808.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| Hikma Pharmaceuticals | 2.39B |
| ConvaTec Group | 1.74B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |